Jacknow D S, Tschann J M, Link M P, Boyce W T
Department of Pediatrics, University of California San Francisco, School of Medicine.
J Dev Behav Pediatr. 1994 Aug;15(4):258-64.
To study the effectiveness of hypnosis for decreasing antiemetic medication usage and treatment of chemotherapy-related nausea and vomiting in children with cancer, we conducted a prospective, randomized, and controlled single-blind trial in 20 patients receiving chemotherapy for treatment of cancer. Patients were randomized to either hypnosis or standard treatment. The hypnosis group used hypnosis as primary treatment for nausea and vomiting, using antiemetic medication on a supplemental (p.r.n.) basis only, whereas the control group received a standardized antiemetic medication regimen. Nausea, vomiting, and p.r.n. antiemetic medication usage were measured during the first two courses of chemotherapy. Anticipatory nausea and vomiting were assessed at 1 to 2 and 4 to 6 months postdiagnosis. Patients in the hypnosis group used less p.r.n antiemetic medication than control subjects during both the first (p < .04) and second course of chemotherapy (p < .02). The two groups did not differ in severity of nausea and vomiting. The hypnosis group experienced less anticipatory nausea than the control group at 1 to 2 months postdiagnosis (p < .02). Results suggest self-hypnosis is effective for decreasing antiemetic medication usage and for reducing anticipatory nausea during chemotherapy.
为研究催眠疗法对减少癌症患儿化疗相关恶心和呕吐的止吐药物使用及治疗效果,我们对20例接受癌症化疗的患者进行了一项前瞻性、随机、对照单盲试验。患者被随机分为催眠组或标准治疗组。催眠组将催眠作为恶心和呕吐的主要治疗方法,仅在必要时(按需)使用止吐药物,而对照组接受标准化的止吐药物治疗方案。在化疗的前两个疗程中测量恶心、呕吐及按需使用止吐药物的情况。在诊断后1至2个月及4至6个月评估预期性恶心和呕吐。在化疗的第一个疗程(p < 0.04)和第二个疗程(p < 0.02)中,催眠组按需使用的止吐药物均少于对照组。两组在恶心和呕吐的严重程度上无差异。在诊断后1至2个月,催眠组的预期性恶心少于对照组(p < 0.02)。结果表明自我催眠对于减少化疗期间止吐药物的使用及减轻预期性恶心有效。